Send your comments and tips to email@example.com
Beth Israel Deaconess Medical Ctr.
Boston Medical Center
Brigham and Women's Hospital
Cambridge Health Alliance
Caritas St. Elizabeth's Medical Ctr.
Children's Hospital Boston
Dana-Farber Cancer Institute
Joslin Diabetes Center
Mass. General Hospital
Mass. Health Law
New England Baptist Hospital
Short White Coat
Tufts-New England Medical Center
UMass Memorial Medical Center
University of Massachusetts
VA Medical Centers
A Healthy Blog
Running A Hospital
Nature Network Boston
SciBos - Corie Lok's blog
Nurse at small
Dr. Gwenn Is In
Healthy Children blog
Other Globe Blogs
Elizabeth Cooney is a health reporter for the Worcester Telegram & Gazette.
Boston Globe Health and Science staff:
Karen Weintraub, Deputy Health and Science Editor, and Gideon Gil, Health and Science Editor.
Short White Coat blogger Ishani Ganguli
Short White Coat blogger Jennifer Srygley
Friday, August 10, 2007
Today's Globe: shots in abortions, Myozyme doses, Alnylam-US pact, heartburn drugs
In response to the Supreme Court decision upholding the Partial-Birth Abortion Ban Act, many abortion providers in Boston and around the country have adopted a defensive tactic. To avoid any chance of partially delivering a live fetus, they are injecting fetuses with lethal drugs before procedures.
Genzyme Corp. is asking adult US patients with Pompe disease to skip two doses of its drug Myozyme in coming months so the Cambridge company can stretch supplies until regulators allow the treatment to be distributed from a new manufacturing plant.
Alnylam Pharmaceuticals Inc. of Cambridge said yesterday that it has been awarded a $38.6 million government contract to develop RNAi therapeutics for biological threats.
The popular heartburn drugs Prilosec and Nexium don't appear to spur heart problems, according to preliminary results of US and Canadian probes disclosed yesterday.